Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. - Wikidata - awgldk - TriplyDB

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

http://www.wikidata.org/entity/Q52145478

about

Global and regional annual brain volume loss rates in physiological aging.The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis.Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.Mindboggling morphometry of human brains.Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis.Gray Matter Involvement in Radiologically Isolated Syndrome.Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome.Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS Reduced rich-club connectivity is related to disability in primary progressive MS Single-subject independent component analysis-based intensity normalization in non-quantitative multi-modal structural MRI.Radiologically isolated syndrome: An update on a rare entity.Critical analysis on the present methods for brain volume measurements in multiple sclerosis.Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment.The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging.Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging.Causes, effects and connectivity changes in MS-related cognitive decline.Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study.Gray matter networks and cognitive impairment in multiple sclerosis.Cognition in multiple sclerosis: State of the field and priorities for the future.Deep grey matter volume loss drives disability worsening in multiple sclerosis.The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis.Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients.Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging.A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease.Unraveling cortical pathology in multiple sclerosis using the T1-/T2-weighted ratio?In vivo detection of connectivity between cortical and white matter lesions in early MS.Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis.The importance of hippocampal dynamic connectivity in explaining memory function in multiple sclerosis.Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study.Progression of regional grey matter atrophy in multiple sclerosis.Time to target brain atrophy and neurodegeneration in multiple sclerosis

P2860

Q30490628-77118DDD-CD74-411A-A0DB-4A498C21249B Q33688161-7F4D9354-5F82-45F8-BAE8-BB56115ECFA2 Q35997017-9161CCE1-B97F-40C0-B96B-BD73194B8DAA Q36288456-26A352C0-32BB-4121-BE6B-74B13FE2CE44 Q37064183-4A4826CC-964A-4406-97C0-69D488A61457 Q37205897-00FB9EC0-F79D-4C45-9018-B4BAE2D0D3BB Q37270766-ABBC4F68-BC62-4564-802D-AC7251ABBAA0 Q37282063-344EDB20-ACC3-4C49-9B6B-F6177386E1BA Q37653515-B6331C54-10A8-4B8B-BB85-80CF6B67575A Q38626531-E96FAD9A-8771-4908-95CE-9FA15390D9EF Q38825436-EB036642-389A-42A0-AD84-5D0B1AFCFCC8 Q38861838-CBEAED01-4218-4AFD-AC1E-A08687E05F10 Q39459514-4D9A961C-AE1F-498A-8487-1D649E1BC42A Q40452260-57B15A70-93E0-4DBF-9375-2618BCD45639 Q41475478-69916D4B-2A50-465E-A836-A4DEE348B9A0 Q46045619-E79FCDD6-316D-4F20-BD72-ECE01F41F13A Q47146933-30A53F84-AE5F-4A4B-A4C6-B52F7212DE19 Q47147953-65F6DE4B-60DE-4E7B-B376-A002789ECD30 Q47438663-B03B2B35-4050-4271-80C5-8330A6358D5A Q47555536-BDCBDC32-1E36-40FC-98B0-E585E1016DD3 Q47726760-07EDC6AF-49A0-4147-B13F-264F3149D24F Q47866122-ECA548E5-A675-47DD-9ECB-881614D078A9 Q47951366-47DF9F28-BEA7-4AEF-B8C9-8CD0C6C662BD Q47975209-9B80BE68-1AD8-4B17-B9EC-EA682CC7F78D Q47975873-3384A3CF-3D63-4B6C-8907-153F9772BE34 Q48310376-53BDA649-5103-40D8-90A8-A92FAED0CF96 Q49247807-9D200B88-2510-4EFA-AE8A-193348B508A4 Q49614715-72042E17-C078-448F-8596-039780183883 Q54408985-935A0B4E-7CC0-4210-92C6-1DD3C9D035CD Q54967864-8E67513F-703C-4E92-896C-213B14DB08D0 Q55264261-0D9DB172-241A-4DC3-9A21-A338559C9F70 Q55282589-A6D652F4-4085-4661-99E8-97DA3AD43936 Q55362467-B4A9301D-992B-4B17-A516-A4B61A819644 Q57744786-155976A3-4FB1-4F75-A6DB-2CF2B7E0E1CB

P2860

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

http://www.wikidata.org/entity/Q52145478

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

@en

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

@nl

type

label

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

@en

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

@nl

prefLabel

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

@en

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

@nl

P1433

Q52145478-BD8F2BE2-D94E-40A8-854C-6BFA48089BE0

P1476

Q52145478-10FCF48A-5B56-4CF2-B736-35406704E3B6

P2093

Q52145478-14BB33D3-F9BB-456D-A474-D7411DAE4B7D

Q52145478-3DEAE7C4-270C-4FC8-AF0F-B325347C08B1

Q52145478-798FFFAD-B6AE-429E-91A6-7F6852A59760

Q52145478-7B4E9D6C-84A1-4F88-B8A7-DB86D1DB040E

Q52145478-7CB24B9C-CE45-406C-9773-5D487C74F9B9

Q52145478-8AA97E13-E25A-41D4-85A9-F0F9D33AA531

Q52145478-8F7B0B7C-8999-4086-A08D-BBC4C573E7AF

Q52145478-A2492758-38C6-4702-9CA8-64AF2E927FFF

P2860

Q52145478-034E2C7A-B78A-4D9F-A983-661F60C99757

Q52145478-0D22B8BE-C6ED-4A52-B97C-046EAC4710D0

Q52145478-13F3236A-E923-4C14-AC11-8A71B238AF46

Q52145478-167AC99F-0DE9-4708-9805-1BC7E1C85E8C

Q52145478-19D63326-C21F-4368-9F6B-134CDE365D0B

Q52145478-1D1ADEC6-E80A-4861-A5B9-C86CB424AC30

Q52145478-20D4ED62-D7AF-4153-87A7-13C97ECB0FB4

Q52145478-22AA81A1-6EAD-49A5-8465-166EA8902592

Q52145478-2B2AAEA2-AB44-4B95-8583-EB247D7BB3E1

Q52145478-2E461BF3-4C87-4B25-A43E-02D862E5E28E

P304

Q52145478-6F3FA72D-8B72-46D1-B92E-ACC32763A77C

P31

Q52145478-52DB667C-1C24-4F25-9347-417E32DAF491

P356

Q52145478-1A6C8452-CC35-4E3D-B191-74AD477755D2

P407

Q52145478-2EA2B98B-EF89-44B3-B3B9-3C74D47931F0

P433

Q52145478-65CF238B-4278-4BB1-AFDF-F59AB07C3916

P478

Q52145478-6198FCF6-77D2-442C-AB09-2F3727629622

P50

Q52145478-875E084E-0262-474F-8469-02A9EBC54AAA

Q52145478-8C975FC8-72A9-4540-A75E-470BC838FF03

Q52145478-920F5ADA-C542-4460-8552-8F40B56B32E1

P577

Q52145478-B4547434-566B-45C4-9FF4-81388B0A18D7

P698

Q52145478-31C622B5-C238-4160-8ED6-240A407F1C5C

P921

Q52145478-4D7ED5D3-FC6D-4D2F-9D9D-9F59A99EB948

P356

P1433

P1476

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

@en

P2093

Bernard M J Uitdehaag

http://www.w3.org/2001/XMLSchema#string

Hugo Vrenken

http://www.w3.org/2001/XMLSchema#string

Jeroen J G Geurts

http://www.w3.org/2001/XMLSchema#string

Lisanne J Balk

http://www.w3.org/2001/XMLSchema#string

Marita Daams

http://www.w3.org/2001/XMLSchema#string

Martijn D Steenwijk

http://www.w3.org/2001/XMLSchema#string

Petra J W Pouwels

http://www.w3.org/2001/XMLSchema#string

Prejaas K Tewarie

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Network collapse and cognitive impairment in multiple sclerosis

Cortical Surface-Based Analysis

An information-maximization approach to blind separation and blind deconvolution

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

Multi-set canonical correlation analysis for the fusion of concurrent single trial ERP and functional MRI.

Measurement and clinical effect of grey matter pathology in multiple sclerosis.

What explains gray matter atrophy in long-standing multiple sclerosis?

P304

115-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWV337

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Frederik Barkhof

Alle Meije Wink

P577

2015-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26637488

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis